Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots
October 01, 2021
From Benzinga
Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx
October 01, 2021
Tickers
QGEN
From Benzinga
AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
September 30, 2021
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
From Benzinga
Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show
September 29, 2021
From Benzinga
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
September 29, 2021
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
September 28, 2021
From Benzinga
AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters
September 27, 2021
From Benzinga
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
September 27, 2021
Tickers
PFE
From Benzinga
NRx Pharma's COVID-19 Candidate Shows Improved Survival At One Year
September 27, 2021
Tickers
NRXP
From Benzinga
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
September 24, 2021
From Benzinga
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
From Benzinga
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
September 24, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends
September 24, 2021
From Benzinga
Novavax Shares Gain After Filing With Serum Institute For WHO Emergency Use Listing For COVID-19 Vaccine
September 23, 2021
Tickers
NVAX
From Benzinga
EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
September 23, 2021
From Benzinga
OraSure Secures $13.6M BARDA Funding For InteliSwab COVID-19 Test 510(k) Clearance and CLIA Waiver
September 23, 2021
Tickers
OSUR
From Benzinga
Valneva Continues To Expand COVID-19 Vaccine Candidate Trials
September 23, 2021
Tickers
VALN
From Benzinga
Vietnam's Health Ministry Approves Phase 2, Phase 3 Cohorts Of Arcturus' COVID-19 Vaccine Trial
September 22, 2021
Tickers
ARCT
From Benzinga
Why Are Dynavax Technologies Shares Skyrocketing Today?
September 22, 2021
Tickers
DVAX
From Benzinga
Immunic, University Medical Center Goettingen Ink Licensing Pact For Combination Viral Infection Treatments
September 22, 2021
Tickers
IMUX
From Benzinga
Corvus Posts Data From Discontinued Mupadolimab COVID-19 Program
September 22, 2021
Tickers
CRVS
From Benzinga
US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations
September 22, 2021
From Benzinga
FDA To Probably Decide On Pfizer/BioNTech COVID-19 Booster Shots By Tomorrow: Bloomberg
September 21, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
